Skip to main content

Capabilities

Capabilities

BridgeLine Translational works with biotech teams, investors, and partners across four capabilities: Competitive Intelligence, Portfolio and Indication Strategy, Preclinical Strategy, and Investor/Partner Readiness.

Where to start

A starting point. Most engagements combine two or three capabilities.

SituationRecommended starting point
An investor or BD team evaluating a target company or sub-sectorCompetitive Intelligence (buy-side)
Choosing whether to commit to a specific biological targetCompetitive Intelligence (target evaluation)
About to make a competitive call (positioning, deal, pivot)Competitive Intelligence (landscape)
A platform with multiple indications and no way to choosePortfolio & Indication Strategy
Allocating capital across multiple active programsPortfolio & Indication Strategy
Sitting on discovery data and need a path to INDPreclinical Strategy
Going into a fundraise or partner meetingInvestor/Partner Readiness

Scope is recommended at the scoping call.

Frequently asked questions

Engagement structure, deliverables, timelines, and scope.

§ / Engage

Contact

BridgeLine Translational. A remote practice, serving biotech clients worldwide.